Slides on Chronic Kidney Disease in Type 2 Diabetes: Contemporary Approaches to Renoprotection

Learn how to evaluate and treat patients with diabetic kidney disease with emerging therapies that promote renoprotection.
George Bakris, MD
Vivian A. Fonseca, MD, FRCP
Susanne Nicholas, MD, MPH, PhD
Format: Microsoft PowerPoint (.ppt)
File Size: 12.69 MB
Released: June 22, 2021

Acknowledgements

Provided by Clinical Care Options, LLC

Contact Clinical Care Options

For customer support please email: customersupport@cealliance.com

Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

Supported by an educational grant from
Bayer HealthCare Pharmaceuticals Inc.

Related Content

Downloadable slides from Clinical Care Options (CCO) featuring expert insights on the clinical trial data supporting the use of tirzepatide in T2D

Carol Hatch Wysham, MD Released: September 2, 2021

Short video from Clinical Care Options (CCO) featuring expert insights on the clinical trial data supporting the use of tirzepatide in T2D

Carol Hatch Wysham, MD Physicians: maximum of 0.25 AMA PRA Category 1 Credits Registered Nurses: 0.25 Nursing contact hours Pharmacists: 0.25 contact hours (0.025 CEUs) Registered Dieticians/Dietetic Technicians, Registered: maximum of 0.25 CPEU(s) Released: September 2, 2021 Expired: September 1, 2022

From Dr. Carol Hatch Wysham and Clinical Care Options (CCO), expert commentary on the role of obesity in the pathogenesis of type 2 diabetes

Carol Hatch Wysham, MD Released: September 2, 2021

Concise video on case studies of continuous glucose monitoring in diabetes from Clinical Care Options (CCO)

Ananda Basu, MD, FRCP
Program Director
Physicians: maximum of 0.5 AMA PRA Category 1 Credits Registered Nurses: 0.5 Nursing contact hours Pharmacists: 0.5 contact hours (0.05 CEUs) Registered Dieticians/Dietetic Technicians, Registered: maximum of 0.5 CPEU(s) Released: August 30, 2021 Expired: August 29, 2022

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue